# Psychosis & Schizophrenia and Bi-Polar Disorder

## Diagnosis
* n/a
  
## Investigation

* Physical Examination: BP; HR; Weight
* FBC
* U+E baseline before Lithium therapy
* TFTs  Thyroid particularly a/w mood
* Alcohol dependency
* Toxicology screen
* ECG Baseline before Haloperidol Long QT
	* Note: Antipsychotics affect metabolism hence check wt, lipids, glucose
	* Note: Smoking cessation impact on antipsychotic metabolism
  
## Management

### Psychosis:
* Acute :Self-harm and suicide risk
* Risk to others: tranquilization (Lorazopam, Haloperidol incl Anti-Cholinergics)
* Conservative:
	* MDT approach assess bio-psych-social
* Medical:
	* Oral antipsychotic + psych intervention
* Antipsychotics:
	* 1st generation – non specific DA antagonist, led to S/E Pyramidal symptoms, akinesthesia prolactinaemia e.g. Acuphase also Haolperidol. S/E prolonging the QT interval
	* 2nd gen; S/E less pyramidal effects but metabolic syndrome e.g. Olanzapine. Neuroleptic malignant syndrome, autonomics
* Must weight up side effects:
	* Metabolic (including weight gain and diabetes)
	* Extrapyramidal (including dyskinesia and dystonia)
	* Cardiovascular (including prolong QT)
	* Hormonal (including increasing plasma prolactin)
* Psychological Intervention
* Family intervention & CBT
  
### Affective (Bi-Polar) Disorder
*  Don’t treat depression, may elevate to mania
* Conservative
	* Calming environments & reduced stimulation
* Medical - only treated in secondary care
	* Olanzapine
	* Sodium valproate: mood stabilizer, evidence
	* Lithium: mood stabilizer

<p class="byline">NICE Source: <cite><a href="https://www.nice.org.uk/guidance/cg178">CG178 Psychosis and schizophrenia in adults: prevention and management</a></cite> and <cite><a href="https://www.nice.org.uk/guidance/cg185">CG185 Bipolar disorder: assessment and management</a></cite>. Summary compiled by <cite class="doctor">Dr D P Sheppard MBBS</cite>.</p>